MedPath

Continued Ventilation During Cardiopulmonary Bypass

Not Applicable
Completed
Conditions
Coronary Artery Disease
Interventions
Other: Non-ventilated Group
Other: Lung Ventilation
Registration Number
NCT01627756
Lead Sponsor
Medical University of Vienna
Brief Summary

Cardiopulmonary bypass (CPB) is well known to induce a strong anti-inflammatory response. The investigators examined whether continued mechanical ventilation during CPB alters systemic immune activation.

Detailed Description

Cardiopulmonary bypass is well known to induce a strong anti-inflammatory response. Studies had been shown that the contact of blood components with artificial surfaces, the surgical trauma, endotoxemia and a reperfusion injury are in part responsible for the seen immunological affect after surgery. The purpose of this study is to test the effect of continued mechanical ventilation during surgery on a blood marker called soluble ST2 in patients sera. Soluble ST2 acts as a decoy receptor of IL-33 and has anti-inflammatory effects. Elevated soluble ST2 concentrations are reported in patients with acute myocardial infarction, sepsis, congestive heart failure and elevates soluble ST2 levels are associated with adverse outcome.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
30
Inclusion Criteria
  • Written informed consent
  • age > 40 and < 80
Read More
Exclusion Criteria
  • treatment with steroids or immunomodulatory interventions during the past four weeks
  • signs of an acute infection
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Non-ventilation GroupNon-ventilated GroupIn the non-ventilated group lungs were collapsed after completion of CPB until after weaning from the extracorporeal circulation.
Ventilation GroupLung VentilationVolume controlled ventilation was done during the whole surgery.
Primary Outcome Measures
NameTimeMethod
Alteration of soluble ST2 concentration in serumPreoperative, postoperative, day 1, day 2, day 3, day 4, day 5 after surgery

Concentration of soluble ST2 will be assessed in the serum of patient´s preoperativem, postoperative and the following five consecutive days after surgery.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Medical University of Debrecen

🇭🇺

Debrecen, Hungary

© Copyright 2025. All Rights Reserved by MedPath